scholarly article | Q13442814 |
P50 | author | Keisuke Kakisaka | Q82520912 |
Gregory J Gores | Q91520926 | ||
Joachim C. Mertens | Q39450778 | ||
P2093 | author name string | Nathan W Werneburg | |
Sophie C Cazanave | |||
Steve F Bronk | |||
Nataliya Razumilava | |||
P2860 | cites work | CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis | Q39709114 |
Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. | Q39829317 | ||
Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity | Q42272663 | ||
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis | Q43292661 | ||
Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy | Q45872868 | ||
Fluorescent detection of lipid droplets and associated proteins | Q46785353 | ||
Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. | Q52652438 | ||
A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein. | Q54340432 | ||
Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver | Q57016669 | ||
Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis | Q80841895 | ||
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis | Q82677113 | ||
Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2 | Q28291091 | ||
Mitochondria and cell death: outer membrane permeabilization and beyond | Q29615459 | ||
AP-1: a double-edged sword in tumorigenesis | Q30014831 | ||
Hepatocellular ballooning in NASH. | Q30430478 | ||
Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder | Q30540440 | ||
Developmental pathways: Sonic hedgehog-Patched-GLI | Q33538044 | ||
Hepatocyte Death: A Clear and Present Danger | Q34147508 | ||
Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system | Q34262892 | ||
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice | Q34408475 | ||
Caspase-independent cell death | Q34433759 | ||
Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. | Q34511187 | ||
Triglyceride accumulation protects against fatty acid-induced lipotoxicity | Q34866329 | ||
Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome | Q34998494 | ||
DRONC coordinates cell death and compensatory proliferation. | Q35071338 | ||
Death receptor 5 signaling promotes hepatocyte lipoapoptosis | Q35604362 | ||
Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis | Q35939383 | ||
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease | Q36402141 | ||
Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye. | Q36514191 | ||
Increased production of sonic hedgehog by ballooned hepatocytes | Q36773522 | ||
Signals from dying hepatocytes trigger growth of liver progenitors | Q36785147 | ||
Cellular and molecular mechanisms of liver injury | Q36908855 | ||
Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell! | Q37251077 | ||
Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of Bcl-2. | Q37335411 | ||
Hedgehog-Gli signaling pathway inhibitors as anticancer agents. | Q37345013 | ||
Mcl-1 degradation during hepatocyte lipoapoptosis | Q37431628 | ||
JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis | Q37446730 | ||
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal | Q37578517 | ||
Ductular reactions in human liver: diversity at the interface | Q37943729 | ||
P433 | issue | 4 | |
P304 | page(s) | 844-851 | |
P577 | publication date | 2012-05-26 | |
P1433 | published in | Journal of Hepatology | Q15724402 |
P1476 | title | A hedgehog survival pathway in 'undead' lipotoxic hepatocytes | |
P478 | volume | 57 |
Q36075087 | Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. |
Q55503094 | Apoptosis and non-alcoholic fatty liver diseases. |
Q40326054 | Association between endotoxemia and histological features of nonalcoholic fatty liver disease |
Q34777399 | Ballooned hepatocytes, undead cells, sonic hedgehog, and vitamin E: therapeutic implications for nonalcoholic steatohepatitis |
Q88431630 | Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease |
Q90047443 | Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis |
Q61099995 | Hepatocyte Lethal and Nonlethal Lipotoxic Injury |
Q57218880 | Inhibitory effects of extracts on palmitate-induced lipotoxicity in HepG2 cells |
Q38799232 | Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis. |
Q38759104 | Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors |
Q37398932 | Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression |
Q33886995 | Liver zonation: Novel aspects of its regulation and its impact on homeostasis |
Q57807657 | Molecular pathways of nonalcoholic fatty liver disease development and progression |
Q49790075 | Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation |
Q30365017 | Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. |
Q45008552 | Reversing Advanced Hepatic Fibrosis in NASH: Clearly Possible, but Widely at Hand? |
Q26743373 | Role of Hedgehog Signaling Pathway in NASH |
Q58758006 | Role of canonical Hedgehog signaling pathway in liver |
Q52349162 | The hedgehog pathway in nonalcoholic fatty liver disease. |
Q54119547 | To die or not to die: death signaling in nonalcoholic fatty liver disease. |
Q34560114 | Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity |
Q46103131 | Using non-thermal irreversible electroporation to create an in vivo niche for exogenous cell engraftment |
Q38747634 | c-Jun N-terminal kinase-mediated Rubicon expression enhances hepatocyte lipoapoptosis and promotes hepatocyte ballooning. |
Search more.